NCT00345826已完成1 期
Long-Term Safety and Efficacy of Dasatinib (BMS-354825) in Subjects Who Experienced Clinical Benefit on Protocol CA 180-002
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- Long term safety and tolerability
研究概览
简要总结
RATIONALE: Dasatinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
PURPOSE: This phase I trial is studying the side effects of dasatinib in treating patients with chronic myelogenous leukemia or acute lymphoblastic leukemia.
详细描述
OBJECTIVES:
Primary
- Determine the long-term safety and tolerability of dasatinib in patients with Philadelphia chromosome-positive chronic myelogenous leukemia or acute lymphoblastic leukemia resistant or intolerant to imatinib mesylate.
Secondary
- Describe any hematologic or cytogenetic response in patients treated with this drug.
- Determine the duration of hematologic and cytogenetic response in patients using this drug during trial UCLA-0303035.
- Determine the progression-free survival and overall survival of patients treated with this drug.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Dasatinib
Experimental
干预措施: dasatinib (Drug)
结局指标
主要结局
Long term safety and tolerability
时间窗: 5 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Dasatinib in Treating Patients With Metastatic Pancreatic CancerAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic CancerNCT00474812National Cancer Institute (NCI)51
终止
2 期
Dasatinib in Treating Patients With Stage IV Pancreatic CancerPancreatic CancerNCT00544908City of Hope Medical Center7
已完成
2 期
Dasatinib in Treating Patients With Previously Treated Malignant MesotheliomaMalignant MesotheliomaNCT00509041Alliance for Clinical Trials in Oncology46
已完成
2 期
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic CancerStage III Pancreatic CancerNCT01234935Translational Oncology Research International8
已完成
1 期
Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic StudyLeukemiaNCT00978731Bristol-Myers Squibb46